Robot-assisted Adrenalectomy, Feasibility and Results
ROBADRE
1 other identifier
observational
700
1 country
1
Brief Summary
To date, laparoscopy is considered to be the gold standard technique for adrenalectomy. Robotic surgery is beginning to be used, but no series of more than 300 procedures has yet allowed the morbidity, benefits and learning curve of this technique to be assessed. Furthermore, the debate on the benefits of using robotic tools when performing adrenalectomies remains open. At Nancy University Hospital, we have been performing robotic procedures on 90% of our patients since 2009, and have seen a significant increase in patient numbers (currently between 80 and 90 per year). In 2019, we published a series of 300 patients, describing the results of the technique. Based on our clinical experience and the growing interest of the surgical community, we believe that describing our cohort of patients who have undergone robot-assisted surgery (estimated at 600 patients) is of unquestionable scientific interest. In 2018, the American team at UCLA published a series of 640 laparoscopic adrenalectomies and examined the risk factors for complications following this surgery. Given the team's reputation and their publication in the leading surgical journal (JAMA Surgery), we used the same criteria for our data collection to make our results comparable. This study aims to evaluate the risk factors for surgical complications after robotic adrenalectomy in a large retrospective series. Our aim is to demonstrate the safety and reliability of this technique and to identify patients at greatest risk of complications. This may encourage the adoption of the technique in other centres.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2025
CompletedFirst Submitted
Initial submission to the registry
July 31, 2025
CompletedFirst Posted
Study publicly available on registry
August 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2026
ExpectedAugust 7, 2025
July 1, 2025
3 months
July 31, 2025
July 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morbidity after robotic adrenalectomy
evaluation of morbidity after robotic adrenalectomy in the 30 days after surgery using Clavien Dindo classification
from enrollment to 30 days after surgery
Secondary Outcomes (3)
factors associated with clavien Dindo morbidity>2
from enrollment to 30 days after surgery
Learning curve
from enrollment to 30 days after surgery
Learning curve - operative time
from enrollment to 30 days after surgery
Study Arms (1)
patients who underwent robot assisted adrenalectomy in University Hospital of Nancy
All patients who underwent a robotic adrenalectomy (all adrenal disease included) in the Department of Visceral,Metabolic and Oncologic surgery in University Hospital of Nancy between 01.01.2013 and 12.31.2025.
Eligibility Criteria
patients who underwent robot-assisted adrenalectomy in Department of Visceral Metabolic and Oncologic surgery Department
You may qualify if:
- all patient who underwent unilateral robot-assisted adrenalectomy
You may not qualify if:
- bilateral adrenalectomy
- adrenalectomy by laparotomy
- partial adrenalectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nomine-Criqui Claire
Nancy, Lorraine, 54000, France
Related Publications (5)
Bihain F, Klein M, Nomine-Criqui C, Brunaud L. Robotic adrenalectomy in patients with pheochromocytoma: a systematic review. Gland Surg. 2020 Jun;9(3):844-848. doi: 10.21037/gs-2019-ra-05.
PMID: 32775278BACKGROUNDGiordano A, Balla A, Prosperi P, Morales-Conde S, Bergamini C. Robotic vs. Laparoscopic Adrenalectomy for Pheochromocytoma-A Systematic Review and Meta-Analysis. J Clin Med. 2025 May 29;14(11):3806. doi: 10.3390/jcm14113806.
PMID: 40507569BACKGROUNDLi X, Xiao S, Yu Y, Liu W, Xi H, Wang G, Zhou X. Robotic-assisted laparoscopic adrenalectomy (RARLA): What advantages and disadvantages compared to retroperitoneal laparoscopic adrenalectomy (RLA)? Front Endocrinol (Lausanne). 2023 Mar 2;14:1145820. doi: 10.3389/fendo.2023.1145820. eCollection 2023.
PMID: 36936166BACKGROUNDChen Y, Scholten A, Chomsky-Higgins K, Nwaogu I, Gosnell JE, Seib C, Shen WT, Suh I, Duh QY. Risk Factors Associated With Perioperative Complications and Prolonged Length of Stay After Laparoscopic Adrenalectomy. JAMA Surg. 2018 Nov 1;153(11):1036-1041. doi: 10.1001/jamasurg.2018.2648.
PMID: 30090934BACKGROUNDGreilsamer T, Nomine-Criqui C, Thy M, Ullmann T, Zarnegar R, Bresler L, Brunaud L. Robotic-assisted unilateral adrenalectomy: risk factors for perioperative complications in 303 consecutive patients. Surg Endosc. 2019 Mar;33(3):802-810. doi: 10.1007/s00464-018-6346-2. Epub 2018 Jul 11.
PMID: 29998394BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor - Head of the endocrine surgery unit of the department of metabolic, endocrine and oncologic surgery
Study Record Dates
First Submitted
July 31, 2025
First Posted
August 7, 2025
Study Start
May 30, 2025
Primary Completion
August 30, 2025
Study Completion (Estimated)
August 30, 2026
Last Updated
August 7, 2025
Record last verified: 2025-07